Abstract

ObjectiveAnalyse the integrated safety profile of evobrutinib, a Bruton’s tyrosine kinase inhibitor (BTKi), using pooled data from multiple sclerosis (MS), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) trials.MethodsPhase II,...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis.
Laura Airas ... Hans-Peter Hartung
Therapeutic advances in neurological disorders | VOL. 17
Laura Airas, et. al.Laura Airas ... Hans-Peter Hartung
01 Jan 2024
POS0657 GEOGRAPHIC VARIATION OF SAFETY IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM
B Combe ... R Besuyen
-
B Combe, et. al.B Combe ... R Besuyen
19 May 2021
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Trial.
Daniel J Wallace ... Anand C Patel
ACR open rheumatology | VOL. 5
Daniel J Wallace, et. al.Daniel J Wallace ... Anand C Patel
18 Dec 2022
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure
Atul A Deodhar ... Bernard Combe
Annals of the Rheumatic Diseases | VOL. 81
Atul A Deodhar, et. al.Atul A Deodhar ... Bernard Combe
07 Apr 2022
View more papers

More From: Journal of Neurology, Neurosurgery & Psychiatry

Paper Title
Journal
Date
Author
Impulse control disorders in Parkinson’s disease: a national Swedish registry study on high-risk treatments and vulnerable patient groups
Mirjam Wolfschlag ... Anders Håkansson
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Mirjam Wolfschlag, et. al.Mirjam Wolfschlag ... Anders Håkansson
30 Jul 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)
Sarah Passoke ... Martin W Hümmert
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Sarah Passoke, et. al.Sarah Passoke ... Martin W Hümmert
30 Jul 2024
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)
Nurit Omer ... Noa Bregman
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Nurit Omer, et. al.Nurit Omer ... Noa Bregman
30 Jul 2024
Endovascular therapy versus best medical management in distal medium middle cerebral artery acute ischaemic stroke: a multinational multicentre propensity score-matched study
Hamza Adel Salim ... Adam A Dmytriw
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Hamza Adel Salim, et. al.Hamza Adel Salim ... Adam A Dmytriw
23 Jul 2024
View more papers